Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$26.12 - $34.07 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024

BUY
$26.64 - $40.31 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024

BUY
$19.95 - $31.0 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023

BUY
$21.33 - $59.42 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023

BUY
$34.33 - $62.11 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023

BUY
$26.01 - $48.69 $0 - $0
0 New
0 $0

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.